Agenerase

Glaxo, Vertex to develop painkiller Dec 13, 2005
BusinessWeek GlaxoSmithKline and Vertex have already successfully partnered on the development of two marketed HIV treatments, Lexiva and Agenerase. ...

Vertex, GSK In Potential $405M VX-409 Preclinical Collaboration Dec 13, 2005
BioWorld Online (subscription), II.". The approved compounds, Agenerase and Lexiva/Telzir, are protease inhibitors marketed by GSK for HIV infection and AIDS. The ...